{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:51:48Z","timestamp":1788292308725,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T01:49:27Z","timestamp":1573782567000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-7880","authenticated-orcid":false,"given":"Chi Young","family":"Ok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-8006","authenticated-orcid":false,"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.008_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.008_bib2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM198805263182106","article-title":"Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma","volume":"318","author":"De Jong","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.008_bib3","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1073\/pnas.85.22.8548","article-title":"Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene","volume":"85","author":"Gauwerky","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.008_bib4","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.008_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/cncr.29781","article-title":"Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma","volume":"122","author":"Landsburg","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.09.008_bib6","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.008_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/leu.2008.344","article-title":"Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations","volume":"23","author":"Niitsu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.008_bib8","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.008_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.2012.01787.x","article-title":"Double-hit BCL2\/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma \u2013 a single centre's experience","volume":"89","author":"Pedersen","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pathol.2019.09.008_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bjh.12982","article-title":"Double hit lymphoma: the MD Anderson Cancer Center clinical experience","volume":"166","author":"Oki","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.008_bib11","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2014-05-578963","article-title":"Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis","volume":"124","author":"Petrich","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.008_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.008_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":"Clinicopathological features of lymphoma\/leukemia patients carrying both BCL2 and MYC translocations","volume":"94","author":"Tomita","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.008_bib15","doi-asserted-by":"crossref","first-page":"38122","DOI":"10.18632\/oncotarget.9473","article-title":"Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC\/BCL2 double hit lymphoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2019.09.008_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/his.12884","article-title":"MYC\/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis","volume":"68","author":"Li","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.008_bib18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3324\/haematol.2013.091827","article-title":"Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma","volume":"99","author":"Aukema","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.008_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2559.2012.04301.x","article-title":"High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and\/or MYC gene rearrangements and a poor prognosis","volume":"61","author":"Kanagal-Shamanna","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.008_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000818","article-title":"Further exploration of the complexities of large B-cell lymphomas with MYC abnormalities and the importance of a blastoid morphology","volume":"41","author":"Moore","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1309\/AJCP7YLDTJPLCE5F","article-title":"\u201cDouble-Hit\u201d mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression","volume":"134","author":"Wu","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1309\/AJCPL11MAHISIJBQ","article-title":"The unique immunophenotype of double-hit lymphomas","volume":"135","author":"Harrington","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3727\/096504015X14500972666761","article-title":"Flow cytometric evaluation of double\/triple hit lymphoma","volume":"23","author":"Roth","year":"2016","journal-title":"Oncol Res"},{"key":"10.1016\/j.pathol.2019.09.008_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cyto.b.21770","article-title":"Bright CD38 expression by flow cytometric analysis is a biomarker for double\/triple hit lymphomas with a moderate sensitivity and high specificity","volume":"96","author":"Alsuwaidan","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.pathol.2019.09.008_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41379-018-0112-9","article-title":"High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma","volume":"32","author":"Ok","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib26","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3109\/10428194.2016.1143939","article-title":"Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges","volume":"57","author":"Moench","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.008_bib27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07528.x","article-title":"BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations","volume":"144","author":"Masir","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.008_bib28","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2019.09.008_bib29","first-page":"344","article-title":"Prognostic significance of MYC single, double, triple hit and MYC-translocation partner status in diffuse large B-cell lymphoma \u2013 a study by the Lunenburg Lymphoma Biomarker Consortium (LLBC)","volume":"132","author":"Rosenberg","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.008_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.008_bib31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/leu.2015.34","article-title":"The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum","volume":"29","author":"Momose","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.008_bib32","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2018.198572","article-title":"Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"104","author":"Evrard","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.008_bib33","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/bloodadvances.2019000251","article-title":"COO and MYC\/BCL2 status do not predict outcome among patients with stage I\/II DLBCL: a retrospective multicenter study","volume":"3","author":"Barraclough","year":"2019","journal-title":"Blood Adv"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2019.09.008_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1182\/blood-2018-99-111530","article-title":"Outcomes of patients with limited-stage aggressive large B-cell lymphoma with MYC rearrangement with and without BCL2 and\/or BCL6 rearrangements: a retrospective analysis from 15 US academic centers","volume":"132","author":"Kothari","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.008_bib35","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.pathol.2019.09.008_bib36","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","article-title":"Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2019.09.008_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1309\/AJCPBWVHTF7RRSA4","article-title":"Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics","volume":"142","author":"Turakhia","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bjh.15653","article-title":"Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"185","author":"Stengel","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.008_bib40","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/modpathol.2017.93","article-title":"Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"30","author":"Quesada","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib41","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/PAS.0000000000000434","article-title":"Triple-hit B-cell lymphoma with MYC, BCL2, and BCL6 translocations\/rearrangements: clinicopathologic features of 11 cases","volume":"39","author":"Wang","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib42","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41379-018-0067-x","article-title":"MYC\/BCL2\/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC\/BCL2 and MYC\/BCL6 double hit lymphomas","volume":"31","author":"Huang","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000478-200004000-00006","article-title":"Blastic\/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases","volume":"24","author":"Natkunam","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1309\/NKK3FEX2BE5L7EKB","article-title":"Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event","volume":"129","author":"Young","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/Y2YD-UNA2-C95R-AVM3","article-title":"Precursor B-lymphoblastic transformation of grade I follicle center lymphoma","volume":"113","author":"Kroft","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib46","first-page":"788","article-title":"Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review","volume":"6","author":"Xu","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/dc.22871","article-title":"Follicular lymphoma transformed to \u201cdouble-hit\u201d B lymphoblastic lymphoma presenting in the peritoneal fluid","volume":"41","author":"Kaplan","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/1179545X17692544","article-title":"Transformation of follicular lymphoma to a high-grade B-cell lymphoma with MYC and BCL2 translocations and overlapping features of Burkitt lymphoma and acute lymphoblastic leukemia: a case report and literature review","volume":"10","author":"Bischin","year":"2017","journal-title":"Clin Med Insights Blood Disord"},{"key":"10.1016\/j.pathol.2019.09.008_bib49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.humpath.2014.10.021","article-title":"Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients","volume":"46","author":"Geyer","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cjp2.10","article-title":"The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit","volume":"1","author":"Clipson","year":"2015","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.pathol.2019.09.008_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0000000000000542","article-title":"High-grade B-cell lymphoma with MYC rearrangement and without BCL2 and BCL6 rearrangements is associated with high P53 expression and a poor prognosis","volume":"40","author":"Li","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/modpathol.2014.95","article-title":"B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC\/BCL2 double-hit lymphomas","volume":"28","author":"Li","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib53","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Green","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.008_bib54","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.008_bib55","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.008_bib56","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","article-title":"High-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","volume":"131","author":"Scott","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.008_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-4608(00)00383-6","article-title":"Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic\/blastoid variant","volume":"126","author":"Mohamed","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2019.09.008_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/modpathol.2017.134","article-title":"Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"31","author":"Miyaoka","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2016.07.025","article-title":"Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature","volume":"58","author":"Miao","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08880018.2015.1087611","article-title":"De novo MYC and BCL2 double-hit B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in pediatric and young adult patients associated with poor prognosis","volume":"32","author":"Liu","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.pathol.2019.09.008_bib61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3960\/jslrt.18003","article-title":"Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement","volume":"58","author":"Ise","year":"2018","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.pathol.2019.09.008_bib62","first-page":"155","article-title":"Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature","volume":"6","author":"Setoodeh","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib63","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Hao","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.008_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.008_bib66","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0000000000001312","article-title":"Mantle cell lymphoma involving skin: a clinicopathologic study of 37 cases","volume":"43","author":"Kim","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.008_bib67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1078-0432.CCR-13-3346","article-title":"Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma","volume":"21","author":"Trabucco","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.008_bib68","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.3109\/10428194.2014.981172","article-title":"ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in \u201cdouble hit\u201d lymphoma cells","volume":"56","author":"Johnson-Farley","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.008_bib69","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1305656110","article-title":"PTEN loss defines a PI3K\/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma","volume":"110","author":"Pfeifer","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.008_bib70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1535-7163.MCT-16-0390","article-title":"Dual HDAC and PI3K inhibitor CUDC-907 downregulates MYC and suppresses growth of MYC-dependent cancers","volume":"16","author":"Sun","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pathol.2019.09.008_bib71","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.008_bib72","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.008_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T08:09:08Z","timestamp":1612339748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519304180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519304180"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.008","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}